PL2344523T3 - Skojarzone szczepionki i środki terapeutyczne przeciw GAS - Google Patents

Skojarzone szczepionki i środki terapeutyczne przeciw GAS

Info

Publication number
PL2344523T3
PL2344523T3 PL09786278.3T PL09786278T PL2344523T3 PL 2344523 T3 PL2344523 T3 PL 2344523T3 PL 09786278 T PL09786278 T PL 09786278T PL 2344523 T3 PL2344523 T3 PL 2344523T3
Authority
PL
Poland
Prior art keywords
therapeutics
combination gas
vaccines
gas vaccines
combination
Prior art date
Application number
PL09786278.3T
Other languages
English (en)
Inventor
Andrea Manetti
Sabrina Capo
Giuliano Bensi
Guido Grandi
Y Ros Imma Margarit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL2344523T3 publication Critical patent/PL2344523T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL09786278.3T 2008-09-17 2009-09-17 Skojarzone szczepionki i środki terapeutyczne przeciw GAS PL2344523T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9755108P 2008-09-17 2008-09-17

Publications (1)

Publication Number Publication Date
PL2344523T3 true PL2344523T3 (pl) 2016-09-30

Family

ID=41508998

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09786278.3T PL2344523T3 (pl) 2008-09-17 2009-09-17 Skojarzone szczepionki i środki terapeutyczne przeciw GAS

Country Status (18)

Country Link
US (2) US20100136041A1 (pl)
EP (1) EP2344523B1 (pl)
JP (2) JP5680536B2 (pl)
CN (1) CN102356090B (pl)
AU (1) AU2009334428B2 (pl)
BR (1) BRPI0919236A8 (pl)
CA (1) CA2737453A1 (pl)
DK (1) DK2344523T3 (pl)
ES (1) ES2566740T3 (pl)
HR (1) HRP20160306T1 (pl)
HU (1) HUE027618T2 (pl)
MX (1) MX2011002760A (pl)
NZ (1) NZ591633A (pl)
PL (1) PL2344523T3 (pl)
SI (1) SI2344523T1 (pl)
SM (1) SMT201600125B (pl)
WO (1) WO2010076618A1 (pl)
ZA (1) ZA201102005B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210128D0 (en) * 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
DK2493498T3 (en) 2009-10-30 2017-05-08 Glaxosmithkline Biologicals Sa Purification of Staphylococcus aureus type 5 and type 8 capsule saccharides
CN103239734B (zh) * 2012-02-10 2016-02-24 北京艾棣维欣生物技术有限公司 用于预防和/或治疗呼吸道合胞病毒感染的疫苗
GB201206366D0 (en) * 2012-04-11 2012-05-23 Absynth Biologics Ltd Bacterial vaccine
EP3400960A1 (en) * 2012-09-18 2018-11-14 GlaxoSmithKline Biologicals S.A. Outer membrane vesicles
CA2945052C (en) 2014-04-15 2023-05-02 Griffith University Group a streptococcus vaccine
WO2015169773A2 (en) * 2014-05-07 2015-11-12 Glaxosmithkline Biologicals S.A. Mutants of spy0269
US10329601B2 (en) * 2015-12-28 2019-06-25 Ionian Technologies, Inc. Nicking and extension amplification reaction (NEAR) of Streptococcus species
CN112442472B (zh) * 2020-11-30 2023-05-26 四川大学华西医院 抗艰难梭菌的重组乳酸乳球菌、活载体疫苗及其制备方法
WO2022158373A1 (ja) * 2021-01-19 2022-07-28 デンカ株式会社 タンパク質、溶血性連鎖球菌ワクチン、ｄｎａ、ベクター、形質転換体、タンパク質を製造する方法、バキュロウイルス、アグロバクテリウム、ラテックス粒子、キット及び抗ストレプトリジンｏ抗体の測定方法
GB202215414D0 (en) 2022-10-18 2022-11-30 Glaxosmithkline Biologicals Sa Vaccine
CN116875520B (zh) * 2023-07-12 2024-06-14 吉林农业大学 表达核糖体失活蛋白的乳酸菌及其在抗轮状病毒中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827038D0 (en) * 1988-11-18 1988-12-21 Kehoe M Streptolysin o antigens & uses
US5866135A (en) * 1994-04-21 1999-02-02 North American Vaccine, Inc. Group A streptococcal polysaccharide immunogenic compositions and methods
US7709009B2 (en) * 2003-07-31 2010-05-04 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for streptococcus pyogenes
CA2583803C (en) * 2004-10-08 2014-11-25 Giuliano Bensi Immunogenic and therapeutic compositions for streptococcus pyogenes
US20110038879A1 (en) * 2006-10-30 2011-02-17 Novartis Ag Immunogenic and therapeutic compositions for streptococcus pyogenes
KR101621837B1 (ko) * 2007-09-12 2016-05-17 노파르티스 아게 Ｇａｓ57 돌연변이 항원 및 ｇａｓ57 항체
WO2009081274A2 (en) * 2007-12-21 2009-07-02 Novartis Ag Mutant forms of streptolysin o

Also Published As

Publication number Publication date
JP2012502969A (ja) 2012-02-02
CN102356090B (zh) 2016-01-20
EP2344523B1 (en) 2016-02-10
HRP20160306T1 (hr) 2016-04-22
JP5680536B2 (ja) 2015-03-04
MX2011002760A (es) 2011-06-16
HUE027618T2 (en) 2016-11-28
BRPI0919236A2 (pt) 2015-12-15
EP2344523A1 (en) 2011-07-20
ES2566740T3 (es) 2016-04-15
SI2344523T1 (sl) 2016-06-30
NZ591633A (en) 2012-10-26
ZA201102005B (en) 2016-09-28
CN102356090A (zh) 2012-02-15
US20150132337A1 (en) 2015-05-14
CA2737453A1 (en) 2010-07-08
AU2009334428A1 (en) 2010-07-08
WO2010076618A1 (en) 2010-07-08
SMT201600125B (it) 2016-07-01
US20100136041A1 (en) 2010-06-03
AU2009334428B2 (en) 2014-02-20
JP2015038156A (ja) 2015-02-26
DK2344523T3 (da) 2016-04-18
BRPI0919236A8 (pt) 2023-01-31

Similar Documents

Publication Publication Date Title
HRP20181493T1 (hr) Konjugati epsilon-polilizin i njihova primjena
ZA201102005B (en) Combination gas vaccines and therapeutics
EP2252333A4 (en) WOUND AND GAS TISSUE TREATMENTS
IL210804A (en) Benzylidenehydrazides and their uses
EP2515946A4 (en) NANOCONJUGATES AND COMPOSITIONS OF NANOCONJUGATES
ZA201109034B (en) Aminopyrrolidinone derivatives and uses thereof
GB0808575D0 (en) Compilign and linking
EP2471799A4 (en) RARE EARTH COMPLEX AND ITS USES
GB0822154D0 (en) Recepatacle and support
ZA201103456B (en) Leukolectins and uses thereof
EP2291377A4 (en) IMIDAZOPYRIMIDINONE AND ITS USES
EP2285405A4 (en) VACCINE COMPOSITIONS AND METHODS
HUP1200449A2 (en) Hydrogen fluoride-hfc-254eb azeotrope and its uses
GB0903299D0 (en) Composition and methods
IL208771A0 (en) Iminopyridine derivatives and use thereof
HK1178526A1 (en) Tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof 8--7-
PL2247601T3 (pl) Tiazopirymidynony i ich zastosowanie
GB0806816D0 (en) Structural foam and manufacture thereof
ZA201103645B (en) Single-time vaccines
EP2430039A4 (en) TTK-PEPTIDES AND VACCINES CONTAINING THEM
GB0912744D0 (en) Methods and uses
IL214453A0 (en) Vangli peptides and vaccines including the same
IL220146A0 (en) Tmem22 peptides and vaccines including the same
EP2504065A4 (en) STABLE MIXTURES AND RELATED METHODS
EP2252305A4 (en) OMENTUM AND ITS USE